Although evidence for involvement of the IL-17 signaling pathway in SLE pathogenesis is expanding, direct interference with IL-17 or it's receptor does not seem to be effective, at least in mouse models (26, 27). This evidence concerns the gene IL17A and systemic lupus erythematosus.